MMV Medicines for Malaria Venture
Geneva, Switzerland
Purpose
to increase post-approval knowledge about the safety and appropriate use of pyronaridine-artesunate in broader patient populations beyond those evaluated in the drug’s clinical development program
Division
Global Health
Date
October 2016
Region Served
AFRICA
Committed amount
$3,507,339
Grant topic
Malaria
Duration (months)
38
Grantee location
Geneva, Switzerland
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.